The two companies will combine and create a leading turnkey solutions provider in the global eye care market with more than EUR 250 million in sales, EUR 48 million in adjusted EBITDA and over 800 employees. The agreed debt-free, cash-free value of the transaction (enterprise value) is EUR 290 million. The consideration payable to the sellers is EUR 250 million, of which EUR 55.7 million will be paid in the form of new shares in Revenio.
Joining forces with Visionix represents a significant milestone in the execution of Revenio’s growth strategy. It is driven by a shared ambition: to create the most innovative, creative and comprehensive entity serving eye care professionals across optometry, optical retail and ophthalmology. While the legal structure is an acquisition, the strategic intent is to bring together two highly complementary businesses, enabling accelerated growth and value creation with greater scale and synergies. The combination will be managed as a partnership of strengths, along with leadership, capabilities and know-how from both companies helping shape the next chapter of the combined group.
Transaction is subject to Revenio's general meeting of shareholders resolving to:
- Authorize the Board of Directors of Revenio to decide on a directed share issue of 2,485,797 new shares to the sellers in connection with the completion of the transaction
- Authorize the Board of Directors of Revenio to decide on an issuance of shares in a planned EUR 80 million post-completion rights issue
Revenio has received an irrevocable undertaking from Revenio’s largest shareholder, William Demant Invest, owning 6,532,461 shares in Revenio, representing approximately 24.48% of the shares, to vote in favor of the proposals of the Board of Directors of Revenio in the annual general meeting of shareholders.
The transaction is expected to be completed by the end of Q2/2026.
More information can be found on Revenio press release.
Below you can find a selection of EY-Parthenon's recent deal alerts and you can also find a more extensive list on our Transactions and Corporate Finance by EY-Parthenon page.